Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Nanjing Leads Biolabs And BeiGene Announce Worldwide License And Collaboration Agreement For LBL-007 Anti-LAG-3 Antibody


RTTNews | Dec 13, 2021 11:10PM EST

23:10 Monday, December 13, 2021 (RTTNews) - Nanjing Leads Biolabs And BeiGene Announce Worldwide License And Collaboration Agreement For LBL-007 Anti-LAG-3 Antibody

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC